The review was initiated following the receipt of a preliminary, non-binding proposal from Eli Glickman, ZIM’s Chief Executive Officer and President, and Rami Ungar, to acquire all outstanding ordinary shares of the company. In response, the Board launched a formal evaluation of strategic alternatives and appointed Evercore as its financial advisor, with Meitar Law Offices and Skadden, Arps, Slate, Meagher & Flom LLP serving as legal counsel.

According to the company, the review process has been underway for several months and encompasses the assessment of a broad range of potential value-creation opportunities. These include, but are not limited to, a possible sale of the company, as well as various capital allocation and shareholder return strategies. The Board has received multiple indications of interest from third parties, including strategic investors, which are currently under review.

ZIM emphasized that there can be no assurance that the strategic review will result in any transaction or specific outcome. The company does not intend to disclose further developments unless and until a definitive agreement is reached or the review process concludes.

In connection with its governance enhancements, ZIM’s Board has recently appointed two independent directors, Yair Avidan and Dr. Yoram Turbowicz. Their appointment strengthens the Board’s financial and transactional expertise, supporting its ongoing evaluation of strategic options aimed at enhancing long-term shareholder value.